The Future of Antibiotics and Artificial Intelligence: Some Thoughts from Discovery to Bedside

Abraham EP, Chain E. An enzyme from bacteria able to destroy penicillin. Rev Infect Dis. 1940;10(4):677–8.

Google Scholar 

Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature. 2016;529(7586):336–43.

Article  CAS  PubMed  Google Scholar 

Bassetti M, Giacobbe DR. A look at the clinical, economic, and societal impact of antimicrobial resistance in 2020. Expert Opin Pharmacother. 2020;21(17):2067–71.

Article  CAS  PubMed  Google Scholar 

Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial resistance. JAMA. 2016;316(11):1193–204.

Article  CAS  PubMed  Google Scholar 

Naghavi M, Vollset SE, Ikuta KS, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199–226.

Article  Google Scholar 

Bassetti M, Giacobbe DR, Vena A, Brink A. Challenges and research priorities to progress the impact of antimicrobial stewardship. Drugs Context. 2019;8:212600.

Article  PubMed  PubMed Central  Google Scholar 

Bassetti M, Larosa B, Vena A, Giacobbe DR. Novel agents in development for the treatment of resistant Gram-negative infections. Expert Rev Anti Infect Ther. 2024;22(11):965–76.

Article  CAS  PubMed  Google Scholar 

Dyar OJ, Huttner B, Schouten J, Pulcini C, Esgap. What is antimicrobial stewardship? Clin Microbiol Infect. 2017;23(11):793–8.

Article  CAS  PubMed  Google Scholar 

Ji B, Ye W. Prevention and control of hospital-acquired infections with multidrug-resistant organism: a review. Medicine (Baltimore). 2024;103(4):e37018.

Article  PubMed  Google Scholar 

Karaiskos I, Galani I, Souli M, Giamarellou H. Novel beta-lactam-beta-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens. Expert Opin Drug Metab Toxicol. 2019;15(2):133–49.

Article  CAS  PubMed  Google Scholar 

Di Pilato V, Codda G, Niccolai C, et al. Functional features of KPC-109, a novel 270-loop KPC-3 mutant mediating resistance to avibactam-based beta-lactamase inhibitor combinations and cefiderocol. Int J Antimicrob Agents. 2024;63(1):107030.

Article  CAS  PubMed  Google Scholar 

Antonelli A, Coppi M, Bonaiuto C, et al. Novel resistance ICEs carrying the bla(FIM-1) metallo-beta-lactamase gene from an ST235 Pseudomonas aeruginosa sublineage. Antimicrob Agents Chemother. 2024;68(2):e0120523.

Article  PubMed  Google Scholar 

Cesaro A, de la Fuente-Nunez C. Antibiotic identified by AI. Nat Chem Biol. 2023;19(11):1296–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Das P, Sercu T, Wadhawan K, et al. Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations. Nat Biomed Eng. 2021;5(6):613–23.

Article  CAS  PubMed  Google Scholar 

Huang J, Xu Y, Xue Y, et al. Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences. Nat Biomed Eng. 2023;7(6):797–810.

Article  CAS  PubMed  Google Scholar 

Maasch J, Torres MDT, Melo MCR, de la Fuente-Nunez C. Molecular de-extinction of ancient antimicrobial peptides enabled by machine learning. Cell Host Microbe. 2023;31(8):1260-74 e6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santos-Junior CD, Torres MDT, Duan Y, et al. Discovery of antimicrobial peptides in the global microbiome with machine learning. Cell. 2024;187(14):3761-78e16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cesaro A, Hoffman SC, Das P, de la Fuente-Nunez C. Challenges and applications of artificial intelligence in infectious diseases and antimicrobial resistance. NPJ Antimicrob Resist. 2025;3(1):2.

Article  PubMed  PubMed Central  Google Scholar 

Rehman AU, Li M, Wu B, et al. Role of artificial intelligence in revolutionizing drug discovery. Fundam Res. 2024;5(3):1273–87.

Article  PubMed  PubMed Central  Google Scholar 

Ross J, Belgodere B, Chenthamarakshan V, Padhi I, Mroueh Y, Das P. Large-scale chemical language representations capture molecular structure and properties. Nat Mach Intell. 2022;4(12):1256–64.

Article  Google Scholar 

Wan F, Torres MDT, Peng J, de la Fuente-Nunez C. Deep-learning-enabled antibiotic discovery through molecular de-extinction. Nat Biomed Eng. 2024;8(7):854–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong F, Zheng EJ, Valeri JA, et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature. 2024;626(7997):177–85.

Article  CAS  PubMed  Google Scholar 

de la Lastra JMP, Wardell SJT, Pal T, de la Fuente-Nunez C, Pletzer D. From data to decisions: leveraging artificial intelligence and machine learning in combating antimicrobial resistance - a comprehensive review. J Med Syst. 2024;48(1):71.

Article  PubMed  PubMed Central  Google Scholar 

Hansch C, Maloney PP, Fujita T, Muir RM. Correlation of biological activity of phenoxyacetic acids with Hammett substituent constants and partition coefficients. Nature. 1962;194(4824):178–80.

Article  CAS  Google Scholar 

Torkamannia A, Omidi Y, Ferdousi R. A review of machine learning approaches for drug synergy prediction in cancer. Brief Bioinform. 2022. https://doi.org/10.1093/bib/bbac075.

Article  PubMed  Google Scholar 

Ma Y, Guo Z, Xia B, et al. Identification of antimicrobial peptides from the human gut microbiome using deep learning. Nat Biotechnol. 2022;40(6):921–31.

Article  CAS  PubMed  Google Scholar 

Liu G, Catacutan DB, Rathod K, et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat Chem Biol. 2023;19(11):1342–50.

Article  CAS  PubMed  Google Scholar 

Stokes JM, Yang K, Swanson K, et al. A deep learning approach to antibiotic discovery. Cell. 2020;180(4):688-702 e13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Polykovskiy D, Zhebrak A, Sanchez-Lengeling B, et al. Molecular sets (MOSES): a benchmarking platform for molecular generation models. Front Pharmacol. 2020;11:565644.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Capecchi A, Cai X, Personne H, Kohler T, van Delden C, Reymond JL. Machine learning designs non-hemolytic antimicrobial peptides. Chem Sci. 2021;12(26):9221–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swanson K, Liu G, Catacutan DB, Arnold A, Zou J, Stokes JM. Generative AI for designing and validating easily synthesizable and structurally novel antibiotics. Nat Mach Intell. 2024;6(3):338–53.

Article  Google Scholar 

Yoshida M, Hinkley T, Tsuda S, et al. Using evolutionary algorithms and machine learning to explore sequence space for the discovery of antimicrobial peptides. Chem. 2018;4(3):533–43.

Article  CAS  Google Scholar 

Zhou Z, Kearnes S, Li L, Zare RN, Riley P. Optimization of molecules via deep reinforcement learning. Sci Rep. 2019;9(1):10752.

Comments (0)

No login
gif